We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requires New Safety Labeling for Lidocaine Products
FDA Requires New Safety Labeling for Lidocaine Products
Manufacturers of oral viscous lidocaine 2 percent solution must add a boxed warning to their product’s labeling that spells out the serious risks of using the painkiller to treat teething pain in children and infants.